Literature DB >> 15729109

Functional and work disability in major depressive disorder.

Heikki J Rytsälä1, Tarja K Melartin, Ulla S Leskelä, T Petteri Sokero, Paula S Lestelä-Mielonen, Erkki T Isometsä.   

Abstract

We examined factors related to social and occupational disability, social adjustment, and work disability among patients with major depressive disorder (MDD), the dominant mental disorder causing functional and work disability. The Vantaa Depression Study comprises a cohort of 269 psychiatric inpatients and outpatients with MDD in the city of Vantaa, Finland. Axis I and II diagnoses were assessed via semistructured WHO Schedules for Clinical Assessment in Neuropsychiatry Version 2.0 and Structured Clinical Interview for DSM-III-R personality disorders interviews. Global disability, social and work adjustment, and being at work or on sick leave were assessed. The most important factors associated with level of social, functional, and work disability were severity and recurrence of depression, but older age and current Axis I and II comorbidity also significantly contributed. Of those employed, almost half (43%) were on sick leave. The most pervasive factors explaining level of functional and work disability among patients with MDD were severity and recurrence of depression. However, older age and comorbidity also contributed.

Entities:  

Mesh:

Year:  2005        PMID: 15729109     DOI: 10.1097/01.nmd.0000154837.49247.96

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  15 in total

1.  DOES HAVING A DYSFUNCTIONAL PERSONALITY HURT YOUR CAREER? AXIS II PERSONALITY DISORDERS AND LABOR MARKET OUTCOMES.

Authors:  Susan L Ettner; Johanna Catherine Maclean; Michael T French
Journal:  Ind Relat (Berkeley)       Date:  2011-01

2.  Admixture analysis of age at onset in major depressive disorder.

Authors:  Tina Zhu; Vincenzo De Luca; Laura Ashley Gallaugher; Hanna O Woldeyohannes; Joanna K Soczynska; Sarah Szymkowicz; David J Muzina; Sidney H Kennedy; Roger S McIntyre
Journal:  Gen Hosp Psychiatry       Date:  2012-08-13       Impact factor: 3.238

3.  The longitudinal joint effect of obesity and major depression on work performance impairment.

Authors:  Yeshambel T Nigatu; Sijmen A Reijneveld; Brenda W J H Penninx; Robert A Schoevers; Ute Bültmann
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

Review 4.  [Life crisis as a consequence of depression and anxiety].

Authors:  Rosa-Maria Lassnig; Peter Hofmann
Journal:  Wien Med Wochenschr       Date:  2007

Review 5.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.

Authors:  Patrick E McKnight; Todd B Kashdan
Journal:  Clin Psychol Rev       Date:  2009-02-07

Review 6.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

7.  Using WHODAS 2.0 to Assess Functional Impairment in People with Depression: Should Employment Receive More Attention?

Authors:  Yu-Chen Chiang; Tsan-Hon Liou; Hsin-Chien Lee; Reuben Escorpizo
Journal:  Int J Environ Res Public Health       Date:  2021-04-25       Impact factor: 3.390

Review 8.  Factors associated with work participation and work functioning in depressed workers: a systematic review.

Authors:  S E Lagerveld; U Bültmann; R L Franche; F J H van Dijk; M C Vlasveld; C M van der Feltz-Cornelis; D J Bruinvels; J J J M Huijs; R W B Blonk; J J L van der Klink; K Nieuwenhuijsen
Journal:  J Occup Rehabil       Date:  2010-09

Review 9.  Incidence rates of sickness absence related to mental disorders: a systematic literature review.

Authors:  Carolyn S Dewa; Desmond Loong; Sarah Bonato; Hiske Hees
Journal:  BMC Public Health       Date:  2014-02-26       Impact factor: 3.295

10.  Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders.

Authors:  Ha-Yeon Kim; Hee-Joon Lee; Min Jhon; Ju-Wan Kim; Hee-Ju Kang; Ju-Yeon Lee; Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.